1-8 of 8
Chin-Hin Ng, MD MRCP, FRCPath
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Feasibility of Outpatient High Dose Cytarabine in Patients with Acute Myeloid Leukemia

Chin-Hin NG, MD MRCP, FRCPATH, MCI, Xiaojuan Chen, BsN, MsN, Foong-Gwan Lee, BsN, Shi Hui Clarice Choong, MBBS, MRCP, Xiao-Shi Saw, BSc(Pharm), Lon-Wann Sai, MBBS, MRCP, Michelle Poon, MBBS, MRCP, FRCPATH, Hian Li Esther Hian Li Chan, MBBS, MRCP, FRCPATH, Melissa Ooi, MB BCh, BAO, MRCP(I), FRCPath, PhD, Yen Lin Chee, MBBS, FRCPATH, PhD, Yee Mei Lee, BsN, MsN, PhD
Journal: Blood
Blood (2019) 134 (Supplement_1): 2152.
https://doi.org/10.1182/blood-2019-129858
Published: 2019
Journal Articles

Whole Exome Sequencing of Relapsed Double-Mutated CEBPA Acute Myeloid Leukemia Identified Mutated KIT and WNT10A As a Potential Co-Mutation with Negative Impact on Prognosis

Chin-Hin NG, MD MRCP, FRCPATH, MCI, Alvin Yu-Jin Ng, PhD, Benedict Yan, MBBS, Wee-Joo Chng, MBBS, PhD
Journal: Blood
Blood (2019) 134 (Supplement_1): 5177.
https://doi.org/10.1182/blood-2019-127727
Published: 2019
Journal Articles

Clinical Outcomes of Phase I/II Clinical Trials for Patients with Relapsed/Refractory Haematological Malignancies: Experience of an Early Phase Clinical Trials Unit

Chin-Hin Ng, MD MRCP, FRCPATH, Dima El-Sharkawi, MD, Elspeth M Payne, MDPhD, Kwee L Yong, Kirit M Ardeshna, MD FRCP, FRCPATH, Asim Khwaja, FRCPath, Rakesh Popat
Journal: Blood
Blood (2016) 128 (22): 3613.
https://doi.org/10.1182/blood.V128.22.3613.3613
Published: 2016
Journal Articles

A Phase I Dose-Escalation Study of the Class 1 Selective Histone Deacetylase Inhibitor CHR-3996 in Combination with Tosedostat for Patients with Relapsed, Refractory Multiple Myeloma: Results of the Muk Three Trial

Rakesh Popat, Sarah R Brown, Avie-Lee Tillotson, Fiona Collinson, Louise M Flanagan, Cathy D Williams, Kwee L Yong, Gordon Cook, MD PhD, Matthew W Jenner, MD, Martin Kaiser, Jim Cavet, FRCPath, Dima El-Sharkawi, MD, Chin-Hin Ng, MD MRCP, FRCPATH, Eric Low, Gareth J Morgan, MD PhD, Faith E Davies, MD
Journal: Blood
Blood (2016) 128 (22): 3321.
https://doi.org/10.1182/blood.V128.22.3321.3321
Published: 2016
Journal Articles

Paediatric-Inspired Acute Lymphoblastic Leukemia Protocols, Are They Too Toxic for Young Adults?

Melissa G. Ooi, MDMRCP FRCPath PhD, Wee J Chng, MD MRCP, FRCPATH, PhD, Chin-Hin Ng, MD MRCP, FRCPATH, Yi Ching Yuen, MClinPharm, BCOP, BCPS, CGP, Allen Eng Juh Yeoh, MD, Chiew Kean Hui, Elaine Seah, BSc
Journal: Blood
Blood (2016) 128 (22): 5162.
https://doi.org/10.1182/blood.V128.22.5162.5162
Published: 2016
Journal Articles

The Plasma Level of Leukemia Stem Cell Specific Antigens - CLL1 and TIM3 Are Predictive of Overall Survival in Acute Myeloid Leukemia

Chin-Hin Ng, MD MRCP, FRCPATH, Ma Thin Mar Win, MBBS, MPH, MHM, Elaine Seah, BSc, Wee-Joo J Chng, MD MRCP, FRCPATH, PhD
Journal: Blood
Blood (2015) 126 (23): 1407.
https://doi.org/10.1182/blood.V126.23.1407.1407
Published: 2015
Journal Articles

Characterization of AML Patients with CEBPA Mutations in a South-East Asian Population

Peak-Ling Lee, Benedict Yan, MBBS, FRCPath, Chin-Hin Ng, MD MRCP, FRCPATH, Kenneth Hon-Kim Ban, MD PhD, Wee-Joo Chng, MBBS, MRCP, FRCPath, PhD, Evelyn Siew-Chuan Koay, FRCPath,PhD
Journal: Blood
Blood (2015) 126 (23): 2574.
https://doi.org/10.1182/blood.V126.23.2574.2574
Published: 2015
Journal Articles

Incidence and Clinical Features of Calreticulin mutation in Patients with Jak2 V617F-Negative Essential Thrombocytosis and Primary Myelofibrosis from Singapore

Chin-Hin Ng, MD MRCP, FRCPath, Christopher W.S Ng, BSc, Bingwen Eugene Fan, MBBS, MRCP, Kiat-Hoe Ong, MBBS, MRCP, FRCPA, Elaine Seah, BSc, Huijun Zhou, MBBS, MSc, PhD, Siew-Chuan Evelyn Koay, FRCPath,PhDBSc,MSc, Wee-Joo Chng, MBBS, MRCP, FRCPath, PhD
Journal: Blood
Blood (2014) 124 (21): 3176.
https://doi.org/10.1182/blood.V124.21.3176.3176
Published: 2014